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ABSTRACT
In recent years, the field of epigenetics has grown
dramatically and has become one of the most
dynamic and fast-growing branches of molecular
biology. The amount of diseases suspected of
being influenced by DNA methylation is rising
steadily and includes common diseases such as
schizophrenia, bipolar disorder, Alzheimer’s
disease, diabetes, atherosclerosis, cancer, major
psychosis, lupus and Parkinson’s disease. Due to
cellular heterogeneity of methylation patterns, epi-
genetic analyses of single cells become a necessity.
One rationale is that DNA methylation profiles are
highly variable across individual cells, even in the
same organ, dependent on the function of the
gene, disease state, exposure to environmental
factors (e.g. radiation, drugs or nutrition), stochastic
fluctuations and various other causes. Using a poly-
merase chain reaction (PCR)-slide microreaction
system, we present here a methylation-sensitive
PCR analysis, the restriction enzyme-based
single-cell methylation assay (RSMA), in the
analysis of DNA methylation patterns in single
cells. This method addresses the problems of cell
heterogeneity in epigenetics research; it is compar-
ably affordable, avoids complicated microfluidic
systems and offers the opportunity for high-
throughput screening, as many single cells can be
screened in parallel. In addition to this study, critical
principles and caveats of single cell methylation
analyses are discussed.
INTRODUCTION
Despite signiﬁcant effort, understanding the causes and
mechanisms of complex non-Mendelian diseases such as
schizophrenia, bipolar disorder, diabetes, Alzheimer’s
disease, Parkinson’s disease and various cancers remains
a major challenge. In recent years, it became evident that
the study of epigenetic mechanisms, which are consistent
with various non-Mendelian irregularities of complex
diseases, may hold the key to the understanding of some
of the characteristics of these disorders (1). One of the
central obstacles hampering progress in the burgeoning
ﬁeld of epigenetics related to human disease is the
inherent cell heterogeneity of a given tissue. Standard
population measurement techniques merely describe
average behavior and are insufﬁcient to investigate vari-
ability among cells (2). Epigenetic analyses traditionally
probe cell ensembles, thereby completely averaging over
relevant individual cell responses, such as differences in
cell proliferation, lack of synchrony of cells in a culture,
responses to external stimuli and disease onset or stochas-
tic events (3). As a consequence, up to now it is impossible
to understand whether a small increase in the methylation
level measured in the ensemble results from a small,
homogeneous increase across all cells or a large increase
in a subset of cells. In cancer studies, methylation patterns
in CpG islands that are important in gene regulation could
be different from cell to cell even in a single tumor tissue.
Cells with distinct epigenetic proﬁles eventually display
distinct phenotypic behavior and drug response (4,5).
For example, variability in adipogenesis activity among
preadipocytes presents signiﬁcant challenges to drug inter-
vention (6). To improve the efﬁcacy of drug treatment, the
source of cell-to-cell variability should be identiﬁed and
targeted. Thus, the ability to detect methylation patterns
of regulatory sequences from a single cell is an essential
factor for understanding the mechanism of tumor initi-
ation, the screening of molecular markers and early diag-
nosis of cancers. This holds true for the molecular
characteristics of most diseased tissues (especially highly
compartmented tissues such as brain or pancreas) where
current analyses are extremely limited by examination of
pooled cell lysates. However, in contrast to one-cell tran-
scriptome analyses, the interrogation of DNA methylation
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of more complex methodologies. As a consequence, epi-
genetic cause of cell-to-cell variability cannot be readily
investigated in an average laboratory setup. For
example, the study of methylation patterns in single cells
using standard equipment such as polymerase chain
reaction (PCR) reaction tubes with 0.2–1.5ml volume is
usually unsuccessful due to numerous reasons, including
partial recovery of cell nuclei, loss of DNA during various
experimental steps, incomplete chemical or enzymatic
modiﬁcation and insufﬁcient ampliﬁcation of the DNA,
among other causes. Indeed, previous attempts to estab-
lish protocols for single cell analyses of methylation
pattern suffered from low success rate and low throughput
(7). In contrast to gene expression analyses, successful
methylation studies using microﬂuidic devices are still
lacking, presumably because microﬂuidic protocols are ex-
pensive, usually have limited multiplexing capabilities, are
laborious or cannot handle the necessary larger number of
chemical or enzymatic steps involved. One of the main
restrictions of microﬂuidic devices is the inefﬁcient
transfer of the analyte (i.e. DNA) between each processing
step and elimination of waste products (8,9). To circum-
vent these limitations, we developed a protocol that is
comparably affordable and contains all the necessary
elements for single-cell DNA methylation proﬁling of
CpG sites integrated in a single device. The protocol
consists of cell placement and cell lysis, enzymatic DNA
fragmentation, cleavage of DNA with methylation-
sensitive restriction enzymes (MSREs) and parallelized
multi-well DNA ampliﬁcation using 48-well slides.
To demonstrate the usefulness of the restriction
enzyme-based single-cell methylation assay (RSMA) tech-
nology in a clinical setup, we chose several CpG island
sequences of genes such as CDKN2A/INK4a (p16) and
COL1A2, which are known to be aberrantly methylated in
various cancers. Interrogation of DNA methylation
patterns in regulatory regions such as CpG islands has
become an important tool for diagnostic purposes and
understanding of tissue-speciﬁc gene regulation in both
normal land pathological conditions. Ultimately, the
basic methodology described in this report may be
adapted to include real-time methylation protocols and
even whole-genome ‘epigenetic’ microarrays (1,10).
MATERIALS AND METHODS
Cell lines
As an epigenetically well-characterized test system, the
human SW480 cancer cell line derived from a colorectal
adenocarcinoma, grade III–IV, was used (11). To study
tissue-speciﬁc effects, human lymphocytes (Pachmann
SIMFO, Dr. Med. Ulrich Pachmann, Bayreuth/
Germany) were analyzed. SW480 cells were cultured
under standard conditions (humidiﬁed incubator, at
37 C and 5% CO2) in Dulbecco’s modiﬁed eagle
medium (DMEM) containing 10% fetal bovine serum
(FBS), 50mg/l gentamycin (Biochrom, Berlin/Germany)
and 100mg/l kanamycin (Biochrom). Human lympho-
cytes were used as delivered. Cells were stained with
Bisbenzimide H33342 (Fluka) in a 10mg/ml ﬁnal concen-
tration and propidium iodide (Sigma) with a 50mg/ml ﬁnal
concentration. Living single cells (propidium iodide
negative) in 1 PBS were deposited on the reaction sites
of AmpliGrid slides (Beckman Coulter Biomedical
GmbH, Advalytix Products, Munich/Germany, BCB) ac-
cording to their physical properties (size, granularity) with
a ﬂuorescence-activated cell sorter (FACS), ﬁtted with an
AmpliGrid slide holder (BCG). Cell deposition was
validated with a ﬂuorescence microscope ﬁtted with a
DAPI ﬁlter. Slides with deposited cells were stored at 4 C.
DNA preparation
A volume of 0.5ml of a 2 % solution of CEK enzyme
(BCG) in 1 reaction buffer was pipetted to the reaction
site of an AmpliGrid slide containing a single cell and
covered immediately with 5ml of sealing solution (BCB).
After complete loading, the AmpliGrid slide was
incubated for 2h at 60 C on an AmpliSpeed slide cycler
(BCB). Subsequently the sealing solution was removed by
dipping the slide into a staining jar ﬁlled with hexane for
30s, followed by drying of the remaining aqueous phase at
37 C on the AmpliSpeed slide cycler.
Methylation-sensitive enzymatic cleavage of DNA
A double digestion solution was prepared containing
0.25U/ml NlaIV (BspLI) and 0.25U/ml MspI, HpaII or
Hin6I in 0.5 Tango buffer. All restriction enzymes
were purchased from Fermentas, St. Leon-Rot/
Germany. For the PCR positive control a single digestion
solution was prepared containing 0.25U/ml NlaIV in
0.5 Tango buffer. For each digestion, 0.5ml of reaction
mix was pipetted to an AmpliGrid reaction site containing
a single cell and immediately covered with 5ml of sealing
solution. The slide was incubated for 6h at 37 Co na n
AmpliSpeed slide cycler followed by a 30-min heat de-
naturation of the enzymes at 65 C. Subsequently, the
sealing solution was removed by dipping the slide into a
staining jar ﬁlled with hexane for 30s followed by drying
of the remaining aqueous phase at 45 C on the
AmpliSpeed slide cycler.
Single-cell PCR
Primers were designed by the Beckman Coulter
Biomedical GmbH primer design service (Advalytix
Products, Munich, Germany) and purchased from
MetaBion, Martinsried/Germany as 100mM solutions in
water. Primer mixes for the COL1A2 promoter: 0.8mM
long forward (50-TTCGGCTAAGTTGGAGGT
ACTG-30), 0.3mM short forward (50-CTAGACATGCT
CAGCTTTGTGG-30) and 0.3mM reverse (50-CTTACA
TTGGCATGTTGCTAGG-30). CDKN2A gene: each
0.5mM for long forward (50-CTCTGGAGGACGAAGT
TTGC-30), short forward (50-CTTCCTGGGGAGTTTTC
AGA-30) and reverse (50-ATTCCTCTTCCTTGGCTT
CC-30). One microliter of each primer mix was pipetted
to a reaction site with restriction-enzyme-treated cells and
dried at 45 C on an AmpliSpeed slide cycler.
Subsequently, 1.65ml of PCR mix containing
1 Multiplex Master Mix (Qiagen, Hilden/Germany)
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Q-solution were pipetted onto AmpliGrid’s reaction sites
and covered immediately with 5ml sealing solution. PCR
program: initial denaturation at 95 C for 10min, followed
by 60 cycles of (30s at 94 C, 1:15min annealing at 60 C
and 1:15min elongation at 72 C), followed by a ﬁnal
10-min elongation step at 72 C. After the ampliﬁcation,
4ml of loading dye (1.25 ) was added to each reaction site
of the AmpliGrid slide. After joining of aqueous phase
and loading dye, 4ml of each PCR product was transferred
to an 8% PAGE gel (Anamed, Gross-Bieberau/Germany)
and separated for 30min at 250V. Silver staining was per-
formed with 0.1% AgNO3-solution for 5min, followed by
a 10s washing step in DI water and development in 0.4M
NaOH/0.1% formaldehyde for 10min.
Bisulﬁte sequencing
DNA from SW480 colorectal cancer cells and from whole
blood was puriﬁed using the QIAamp mini kit and
QIAamp DNA blood mini kit (Qiagen), respectively, ac-
cording to the manufacturer’s standard protocols.
Bisulﬁte treatment was performed using a modiﬁed
standard protocol after Clark et al. (12). Brieﬂy, 500ng
genomic DNA was split into four reactions and separately
fragmented by EcoRI, PvuII and HindIII (Fermentas). In
the fourth reaction, DNA was sheared brieﬂy (1–2s) with
an ultrasound sonicator. After heat inactivation of the
enzymes, all reactions were combined and then puriﬁed
using a MiniElute reaction cleanup kit (Qiagen) and
eluted in 35mlH 2O. Bisulﬁte conversion was performed
using an EpiTect Bisulﬁte Kit (Qiagen) according to the
manufacturer’s manual and ﬁnally eluted in 20mlE B
buffer. Bisulﬁte-treated DNA was stored at  80 C until
needed. 10ml of each sample was used for bisulﬁte
hot-start PCR in 25ml volume reactions containing 1mM
primers, and a master mix containing TrueStart Taq poly-
merase (Fermentas). PCR program: Initial denaturation
at 95 C for 2min, followed by 35 cycles of (20s at 94 C,
1:10min annealing at 61.5 C and 1min elongation at
72 C), followed by a ﬁnal 10-min extension step at 72 C.
CDKN2A bisulﬁte primer: F: 50-GTAGTATGGAGTTT
TYGGTTGATTG-30;R :5 0-AAAAACTAAATAATCCC
AACACATCTT-30 (product size 498bp). COL1A2
bisulﬁte primer: F: 50-GGAGGTATTTTAGGGTTAGG
GAAAT-30;R :5 0-CAAACAAACTAAAAACACTTAC
ATTAA-30 (product size 295bp). All PCR reactions
were checked on a 1.0% agarose gel to ensure successful
ampliﬁcation and speciﬁcity before proceeding with
sequencing. The ampliﬁcation product of the expected
size were cut from the gel and puriﬁed by QIAquick gel
extraction kit (Qiagen). PCR products were diluted to
2ng/ml and subjected to direct sequencing (Euroﬁns
MWG Operon, Ebersberg/Germany).
Pyrosequencing
Primers were designed with Pyrosequencing Assay Design
Software v1.0.6 (Biotage, Uppsala, Sweden). The
CDKN2A locus was designed to span the region contain-
ing the same HpaII and Hin6I sites that were interrogated
with RSMA. A full list of primer sequences can be found
in Table S1. Bisulﬁte conversion of genomic DNA and
pyrosequencing were performed as described previously
(13). All PCR reactions were checked on a 1.0% agarose
gel to ensure successful ampliﬁcation and speciﬁcity before
proceeding with pyrosequencing.
RESULTS AND DISCUSSION
The proposed RSMA method uses a classical proﬁling
approach with MSREs to interrogate methylation
patterns at speciﬁc CpG dinucleotides. RSMA comprises
four main steps (Figure 1): (i) deposition of single cells
onto the microreaction sites; (ii) cell lysis and removal of
DNA-bound proteins; (iii) methylation-sensitive restric-
tion of DNA; and (iv) ampliﬁcation of the interrogated
DNA sequences. The ﬁnal ampliﬁcation is performed with
two forward primers and one reverse primer (Figure 1B).
The restriction sites for the MSREs are located between
the two forward primers. In case the ampliﬁed DNA
fragment is methylated, the restriction enzymes will not
cleave, resulting in two ampliﬁcation products. If the
DNA is unmethylated, only the short ampliﬁcation
product is synthesized during the PCR. The resulting
DNA products are ﬁnally separated on a gel, where the
short band serves as positive PCR control. A large number
of MSREs can be used with RSMA, enabling the interro-
gation of nearly every gene or promoter in a mammalian
genome (1).
AmpliGrid slides, commonly used for single-cell PCR
applications, were chosen as reaction platform (14). Each
slide contains 48 independent hydrophilic reaction sites
surrounded by a hydrophobic circle which holds
aqueous reaction solutions, such as enzyme buffers, in
place (Figure 1A). Cells were deposited on the slide
surface by ﬂow cytometry cell sorting. Before each experi-
ment, the correct deposition of single cells on the reaction
sites was veriﬁed with a microscope. The ﬂatness of the
glass substrate allows a simple optical control of the whole
workﬂow using a microscope or a slide scanner. Lysis of
single cells was performed with a protease solution (CEK)
which digests proteins associated with DNA. A heat in-
activation of CEK is not required as it is almost com-
pletely inactive under the conditions where most MSREs
are predominantly active (37 C).The relatively low CEK
reaction temperature (60 C) keeps the DNA double-
stranded, a necessary prerequisite for the subsequent en-
zymatic cleavage. To prevent evaporation and cross-
contamination, each reaction was covered with 5mlo fa n
oil-based sealing solution (see ‘Materials and Methods’
section). After the proteolysis, the sealing solution was
removed and the aqueous droplets air-dried. The drying
step is required to prevent a surplus dilution of the
reaction mix in the methylation-sensitive cleavage and
DNA fragmentation. Restriction enzymes should be
added in 0.5ml of 0.5 restriction enzyme buffer,
because higher buffer concentrations may result in inhib-
ition of the following PCR reaction. Additionally, a
reduced ampliﬁcation efﬁciency using some restriction
enzyme buffers was recognized (data not shown). Hence,
the ﬁnal PCR ampliﬁcation is performed in a relatively
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preceding reactions as much as possible. Single-cell
methylation-sensitive PCRs have to be highly efﬁcient
and sensitive as only one to two copies of the target
sequence is present; hence, speciﬁc care has to be taken
to avoid problems that may cause decreased ampliﬁcation
efﬁciency. One problem during ampliﬁcation steps is the
mixed hydrophobic–hydrophilic nature of biological
macromolecules, which leads to their adsorption to a
variety of surfaces; often the DNA molecules stick to
reaction vessels, which may interfere with the ampliﬁca-
tion. This characteristic may result in a signiﬁcant loss of
sample or in the possible inaccessibility of certain DNA
sequences for several initial PCR cycles and eventually
becoming accessible only later during the ampliﬁcation.
Indeed, we found that an increase from a standard
30-cycle ampliﬁcation to  60 cycles can improve the
PCR performance signiﬁcantly (data not shown). In ex-
pression studies, such cycle numbers may introduce dis-
tortions in the measured gene expression levels. However,
when performing methylation analysis the high cycle
number is not a disadvantage per se as the cell contains
only one or two copies of each locus which is either
methylated or not and no intermediate methylation
levels exist. In theory, this information can be used to
transform the methylation status of each CpG dinucleo-
tide into a binary code for subsequent biostatistical
analyses. Moreover, a large number of PCR cycles are
essential since the ampliﬁcation products are usually
located within GC-rich regions that favor the formation
of stable intramolecular hairpin structures interfering with
the annealing of the primers. This is generally not a
problem for conventional PCR with a high number of
DNA templates, but can be crucial in single-cell PCR,
where the amount of starting material is low. The occur-
rence of hairpin structures also requires special care in
primer design for single-cell methylation proﬁling applica-
tions. To avoid primer sequences that are located in
regions susceptible to hairpin structures in the chosen
PCR conditions, the target regions were analyzed for
their folding properties using the SirGraph package
(Supplementary Data) (15). In our experience, primer an-
nealing can also be enhanced by using a higher concentra-
tion of primers, which is often important for improving
the ampliﬁcation efﬁciency of the long PCR product.
Another key component for a successful single-cell PCR
is the complete denaturation of the DNA template at the
beginning of the PCR. Incomplete denaturation of the
DNA results in an inefﬁcient utilization of template in
the earliest ampliﬁcation cycles leading to poor yield of
PCR product or may interrupt ampliﬁcation.
Consequently, the initial denaturation should be per-
formed over an interval of at least 5–8min at 95 C if the
GC-content of the desired DNA sequence is 50% or less.
This interval should be extended up to 10min for GC-rich
templates such as gene promoters. In our experiments, the
Figure 1. Principle of the RSMA test system for the analysis of DNA methylation patterns in single cells. (A) Single cells from various sources are
placed on high-throughput multi-well PCR slides (one cell per well), either by micromanipulation, laser capture microdissection or ﬂow cytometry
cell sorting. The protocol was tested with AmpliGrid microreaction slides, which are composed of a standard microscope slide sized glass surface
with chemically structured, DNA free reaction centers. The reaction volume ranges from  500nl up to 1.65ml, small enough to sufﬁciently con-
centrate the reaction volume to a point where enzymatic steps proceed with high kinetics, but large enough to sufﬁciently dilute the cellular
components ( 1pl) of each cell. It is possible to perform 48 methylation-proﬁling reactions on one 75mm 25mm slide. The structure of the
slides allows carrying out methylation-sensitive PCRs from single cells that can be lysed directly on the reaction centers, thereby generating
methylation proﬁles starting with DNA amounts as low as 6pg. The hydrophilic and hydrophobic regions on the slide surface ensure that even
after inaccurate pipetting the droplets containing single cells will ﬁnd their way to the correct position. An important feature of this technology is the
parallel analysis of multiple cells, a desirable feature that makes it possible to obtain statistically relevant methylation data on single cells in a
reasonable time frame. (B) DNA is fragmented by a restriction enzyme (here NlaIV), that cleaves outside of the target region. Primer mixes contain
two forward primers (F1+F2) and one reverse primer (R). The analyzed CpG dinucleotides (here HpaII and Hin6I sites) are located between the
two forward primers. If the restriction site is methylated, the restriction enzyme cannot cleave and both PCR products are synthesized, whereas for
unmethylated restriction sites only the short PCR product (internal PCR positive control) is produced.
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merase, which itself requires an initial denaturation step to
be fully activated, resulted in good and sufﬁcient
ampliﬁcation.
Single-cell proﬁling in human cancer cell lines and
lymphocytes
RSMA can be applied with a variety of enzymes and
protocols (e.g. real-time measurements and multiplexing,
among others); however, to illustrate the overall
approach, we demonstrate a simple protocol, that
requires two very commonly used MSREs in epigenetics
research, HpaII and Hin6I. A comprehensive list of po-
tential restriction enzymes with genomic coverage for
DNA methylation proﬁling can be found in Schumacher
& Petronis 2006 (1). One rationale in using the classical
proﬁling approach with MSREs is the potential to use the
data and principles of single-cell methylation proﬁling
derived from this study to develop further protocols
with higher genomic coverage. Indeed, the interest in
MSREs is now resurging as these enzymes are the key
tools for large-scale epigenomic proﬁling using micro-
arrays (1) and next-generation sequencing (NGS)
approaches (16), which ultimately may lead to the devel-
opment of single-cell whole methylome technologies.
To validate the RSMA method, restriction sites located
in the promoter region of two genes (COL1A2 and
CDKN2A) were analyzed in the human colorectal
cancer cell line SW480 and in human lymphocytes. In
initial screenings, the FGF19 and RARB gene promoters
were also analyzed; however, we detected only
unmethylated CpGs in the interrogated cells (Figure 1B).
Hence, we focused our analysis on the well-characterized
collagen type I alpha 2 (COL1A2) and cyclin-dependent
kinase inhibitor 2A (CDKN2A) genes, which are known
to exhibit cancer- and tissue-speciﬁc methylation patterns.
A number of reports have demonstrated the silencing of
COL1A2, a candidate tumor suppressor gene, due to
aberrant methylation within the promoter region in
primary cancer tissues and in several cancer cell lines
(17,18). Similarly, CDKN2A, a known tumor suppressor
gene, is either mutated or deleted in a wide range of
cancers and in addition has been found to be silenced by
CpG methylation in many tumor types (19–21).
To assess the restriction enzyme efﬁciency in the chosen
model system, DNA from single cells was also cleaved
with MspI, an isoschizomer of HpaII, which cuts inde-
pendent of the CpGs methylation status. If a digestion
was successful, ampliﬁcation of the interrogated regions
should only produce the short ampliﬁcation product
(Figure 1B). All MSRE cleavage reactions were performed
as double digests together with NlaIV (50-GGN^NCC-30).
The main purpose of NlaIV, which cleaves independent of
methylation status, is the fragmentation of the genomic
DNA. Without fragmentation, we observed a signiﬁcantly
decreased processivity for the long PCR product of several
different genes (data not shown). In our experimental
setup, NlaIV does not cleave within the ampliﬁed DNA
sequence, but close to the primer annealing sites outside
the long PCR products (Figure 1B). As positive control
for PCR efﬁciency, only a single digestion with NlaIV was
performed.
In total, we analyzed 429 single cells for COL1A and
CDKN2A (Figure 2). In 1.5% of the ampliﬁcation reac-
tions using the SW480 cells, and in 5% of reactions with
lymphocytes, the PCR yielded no product (on average 3%
of all ampliﬁcations).
On average, our analysis showed that in 91% of the
SW480 cells the analyzed HpaII restriction site within
the COL1A2 promoter was methylated (Supplementary
Figure S2). Comparable methylation percentages were
obtained for the Hin6I site, where in 87% of the cells
CpG methylation was observed. The opposite pattern
was found in lymphocytes, with most cells being
unmethylated. Only 5% of the analyzed sites were
methylated. These numbers are in agreement with pub-
lished data for SW480 cells, which were reported to be
hypermethylated (>80% methylation) at the +7 site in
the COL1A2 promoter compared to non-cancer tissues
(22). This increased methylation of the collagen gene in
colorectal cancer cells was inversely correlated with
collagen messenger RNA (mRNA) steady-state levels.
Similarly, in our experiment, the CDKN2A promoter
was found to be almost completely methylated in SW480
cells (99%), but relatively hypomethylated in lymphocytes
(21%). Again, our results are in agreement with previous
studies, which reported methylation levels of the
CDKN2A promoter between 92% and 100% in SW480
cells and no signiﬁcant methylation in blood cells (20,23–
25). Additionally, using a methylation-speciﬁc polymerase
chain reaction followed by analysis of the methylated
cytosine content of the product by thermal denaturation,
a recent study by Kovatsi and co-workers (26) also
described a partial methylation of the CDKN2A
promoter in peripheral blood samples from healthy
individuals.
Overall, the single-cell data show the expected signiﬁ-
cant difference between the SW480 cancer cells and
lymphocytes. It is important to note that relatively
similar methylation levels were obtained for the closely
spaced HpaII and Hin6I restriction sites within the same
cell type and the same promoter region. This ﬁnding indi-
cates that the methylation status of each CpG dinucleotide
within the same promoter may be representative for the
methylation status of surrounding CpG sites. This ﬁnding
is signiﬁcant as only a subset of CpGs in CpG islands is
recognized by speciﬁc methylation sensitive restriction
enzymes and therefore suitable for methylation proﬁling.
To validate our RSMA results, we performed direct
bisulﬁte sequencing on the CDKN2A and COL1A2
promoter regions as well as quantitative pyrosequencing
of the downstream CDKN2A HpaII and Hin6I sites. As
exempliﬁed for the CDKN2A promoter, direct sequencing
of PCR products from bisulﬁte-treated DNA revealed
hypermethylation (>98%) of both gene promoters in
SW480 cells, whereas both CpG islands revealed to be
hypomethylated in lymphocytes (Figure 3). Additionally,
pyrosequencing of the 30 border of the CDKN2A
promoter in additional lymphocyte DNA samples
revealed residual DNA methylation level (up to 18%),
conﬁrming our RSMA data (Supplementary Figure S3).
PAGE 5 OF 9 Nucleic AcidsResearch, 2011, Vol.39,No. 7 e44These results underscore the power of the RSMA
approach, as more detailed methylation data can be
produced compared to direct sequencing. The observed
variation of methylation patterns between individual
cells of the same cell type illustrates that a certain stochas-
tic variation exists, which would be masked by conven-
tional bulk measurements. Bisulﬁte sequencing may not
be the ﬁrst choice for single-cell methylation proﬁling
because treatment with bisulﬁte signiﬁcantly degenerates
the four nucleotide code (1), which results in the loss of
speciﬁcity of a large portion of the genome and increases
the chance of cross hybridization of PCR primers.
Additionally, due to the harsh conditions, a certain per-
centage of DNA degrades during bisulﬁte conversion, a
decisive disadvantage when working with a limited
amount of DNA. As a consequence, conventional bisulﬁte
sequencing requires several hundred or even thousands of
cells in order to obtain a sufﬁcient amount of DNA for
analysis. Obtaining this number of cells of a single type is
challenging, particularly when attempting to study rare
stem cells such as tumor-forming cancer stem cells
(CSCs) (27,28). Therapeutic innovations may emerge
from a better understanding of the epigenetic mechanisms
of CSCs. The high-throughput RSMA technology has the
potential to transform such single-cell methylation
analyses from a major technological challenge to a
routine procedure for research and clinical diagnostics.
Critical parameters for single-cell methylation proﬁling
In our experiments, we studied several other important
parameters that may prove crucial in single-cell analyses.
For example, in rare cases, we observed incomplete diges-
tion of the DNA, most likely due to aged cells that were
stored on the microreaction sites for longer periods.
Usually, cells can be stored on the reaction sites for
several months; however, we found that cells stored for
more than 3 months increased the rate of failed reactions
(e.g. incomplete digestion or repressed ampliﬁcation) sig-
niﬁcantly. For example, control digestion with MspI,
which should always produce only the small PCR
product, failed in  7% of experiments when using old
cells. Similarly, NlaIV digests failed in about 9% of old
cells, whereas incomplete digestion was nearly absent in
freshly prepared cells. In general, DNA methylation
patterns are known to be stable in post-mortem tissues
(29) and storage of cells on the slides should not affect
the DNA methylation patterns as the cells are dried and
no enzymatic activity is to be expected.
The main reason for the lack of technologies to study
single-cell methylation patterns can be attributed to the
poor yields encountered when subjecting mammalian
cells to multiple enzymatic or chemical processes. In our
experience, to circumvent these problems, it is advanta-
geous to perform all experimental steps in a single
reaction vessel, without transfer of the components.
Ideally, to avoid loss of DNA, pumping (circulation) of
solutions should be avoided. So far, researchers focusing
on epigenetic proﬁling of a limited number of cells rely on
microplates or standard reaction tubes for their assays. As
a result, large dead volumes, template adsorption and no
optical quality control are responsible for a considerable
uncertainty and low reproducibility. We found that using
microreaction slides could overcome all of these problems,
whereas using standard reaction vessels, such as 0.5ml
PCR tubes resulted in inconsistent or completely failed
enzymatic reactions (data not shown). For kinetic
reasons, it is advantageous to perform enzymatic reactions
in very small volumes, but, on the other hand,
large-enough dimensions (>0.5ml) to allow for reaction
components to be easily transferred or added between
reaction steps in a standard laboratory setup.
Another crucial step is the complete lysis of the cell and
removal of unwanted proteins before enzymatic reactions
Figure 2. Polyacrylamide gel electrophoresis of products from multiple parallel single-cell PCRs as exempliﬁed for the CDKN2A promoter. Each
lane represents a PCR product from a single cell in SW480 cells (top row) and lymphocytes (bottom row). All of the SW480 cells in the presented
slide contained only fully methylated HpaII and Hin6I sites, indicated by the presence of two bands, the uncleaved (methylated) long band (191bp,
F1/R) and the short control band (157bp, F2/R). In contrast, most of the lymphocytes contained only the short band, indicating that the analyzed
CpG dinucleotides were unmethylated. Some cells were treated with MspI/NlaIV as control for the enzymatic reaction and should produce only the
short band. In parallel, some cells were treated with NlaIV alone, which serves as positive control for the long PCR product. If the chosen PCR
conditions are appropriate, both ampliﬁcation products should be visible. Typically, the short control band is noticeable weaker compared to the
long band, which may be explained by the fact that in later PCR cycles the short band may also serve to a signiﬁcant extent as primer for the long
PCR product. In addition, due to better hybridization efﬁciency, the longer PCR product may be ampliﬁed preferentially. M, methylated; U,
unmethylated.
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important because an individual cell’s total cellular
protein content is quite high, averaging 8 10
9 molecules
per cell, which is about equal to 700pg (3). Many of the
proteins, especially histone and transcription factors, are
bound to the DNA and hence can interfere with analysis.
The small absolute amount of DNA and the low DNA
concentration compared to cellular proteins presents sig-
niﬁcant challenges for detection. Efﬁcient proteolytic steps
have to be applied to ensure that the minute amount of
DNA can be enzymatically processed and ampliﬁed by
PCR. In our experience, a 2-h treatment with CEK
protease (see ‘Material and Methods’ section) was sufﬁ-
cient to lyse the cell and free the DNA from proteins for
subsequent enzymatic treatment.
Another very crucial step in single-cell methylation
proﬁling is the very quick transfer of the freshly
prepared cell to the reaction site, followed by immediate
drying or lysis of the cell. The act of placing a cultured
(adherent) or microdissected cell into suspension for
transfer into the analytical devices may damage the cell
membrane and activates various signaling or apoptotic
pathways. This in turn may disturb the epigenetic machin-
ery of the cell, ultimately resulting in technically biased
methylation patterns. For example, embryonic stem (ES)
cells are easily affected by culture conditions and in vitro
manipulation, which could in turn result in increased vari-
ability in the methylation and transcription patterns of the
ES cell genome. Indeed, previous work on ES cells has
shown that stem cell-derived tissues and embryos often
fail to maintain stable epigenetic states (30,31). Often, epi-
genetic instability is reported in differentially methylated
regions of mostly growth-related imprinted genes, but less
often neuronal genes (32). The tendency for living cells to
be perturbed by in vitro manipulation imposes stringent
requirements in performing a successful biological experi-
ment. Changes in the cell’s environment such as
nutrients, pH, ionic strength and temperature can lead
to variation in the intracellular concentrations of many
molecular species involved in methylation homeostasis.
Furthermore, epigenetic patterns are in a constant state
of ﬂux, e.g. cyclical methylation and demethylation of
CpG dinucleotides at speciﬁc loci may occur within
minutes (33). Hence, in some single-cell studies, careful
consideration of cell-cycle status and transfer time to the
reaction site for quick drying are warranted.
In contrast to expression studies, DNA methylation
analysis of single cells are even more sensitive to
Figure 3. Bisulﬁte sequencing of larger cell populations to verify the results from single-cell measurements. (A) Direct sequencing of the CDKN2A
core promoter region revealed hypermethylation of all of the analyzed CpG dinucleotides within the promoter CpG island in colorectal cancer cells,
whereas no signiﬁcant methylation in lymphocytes could be detected. The small methylation level in the HpaII and Hin6I sites can be explained by
their location at the CpG island downstream border, after which methylation levels increase. The black areas of the lollipops represent the average
degree of methylation for each CpG dinucleotide, determined by semiquantitative measurement of peak height for each nucleotide from multiple
bisulﬁte sequence electropherograms. Gray lollipops=no sequencing data. (B) Structure and analyzed sequence of the CDKN2A gene. Sample
sequencing traces from different tissues are shown on the bottom. The bisulﬁte sequencing results conﬁrm the methylation data derived from
single-cell methylation proﬁling by the RSMA technology.
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signiﬁcantly alter the result, whereas a single RNA
molecule would—in most cases—not dramatically alter
the measured expression levels. Given the potential for
contamination from even very small amounts of DNA, a
useful microreaction system will likely need to be single
use.
Another difﬁculty when studying single diploid cells
comes from heterozygous DNA methylation that can be
found, for instance, in imprinted genes where each allele
can be differentially methylated depending on its parental
origin. Depending on the applied protocol, assessing the
exact methylation pattern can be challenging. For
example, in our protocol, if only one allele is methylated,
the resulting banding patterns in the gel will look similar
to fully methylated sequences (two PCR bands), only with
a higher intensity of the low-molecular PCR product.
Consequently, to conﬁrm heterozygous methylation, the
resulting amount of each PCR product would have to be
carefully measured, such as by quantitative real-time PCR
(qPCR).
An additional caveat for single-cell approaches is that
stochastic biological events or even the chance analysis of
a very rare cell can create noise which may confound ob-
servations. Hence, single-cell methylation proﬁling must
retain the capacity to perform population statistics
(therefore a need for high-throughput). Although the
general level of cell-to-cell epigenetic variation in
mammals is still largely unknown, it can be expected
that the cell’s epigenetic machinery is inherently noisy. It
could be shown that signiﬁcant differences in gene expres-
sion levels exist between phenotypically identical cells
in vivo, and that these differences exceed any noise contri-
bution from global mRNA ampliﬁcation (34). Due to the
highly parallelized methodology, RSMA also offers the
opportunity to study stochastic inﬂuences in methylation
dynamics, an important component of epigenetic drift
(1,35,36). Indeed, it was suggested that a substantial
portion of phenotypic variance in disease and aging, trad-
itionally attributed to environmental effects, may in fact
result from stochastic epigenetic events in the cell (1). By
studying methylation patterns in multiple single cells (up
to 48 cells per slide) under controlled environmental con-
ditions, quantiﬁcation of stochastic events becomes
possible. The typical channel dimensions found in
microﬂuidic devices (10–100mm) and the ability to ma-
nipulate nanoliters of reagents on-chip have made these
devices encouraging platforms for the analysis of single
cells. However, most of these systems do not possess a
high-throughput capacity or they are too expensive for
the daily use in most laboratories. With our proposed
system, high-throughput as well as cost efﬁciency can be
ensured.
CONCLUSIONS
In summary, we demonstrated an affordable technology
to assess the methylation patterns of CpG dinucleotides
in single cells. RSMA offers the opportunity for
high-throughput screening, as many single cells can be
screened in parallel. This method may prove to be espe-
cially useful for clinical studies, as the procedure is
straightforward and does not require complex
microﬂuidics devices. By coupling RSMA with
micromanipulation, laser capture microdissection, or
ﬂow cytometry cell sorting, the heterogeneous nature of
tumors, neurodegeneration and other complex disorders
can be investigated at the single-cell level. Overall, it is
argued that single-cell epigenetic strategies such as
RSMA, when applied in parallel with the traditional
genetic ones, may signiﬁcantly advance the discovery of
etiopathogenic mechanisms of complex diseases and sto-
chastic epigenetic variance.
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